Fresh Approach to Clinical Trials: Perspective from India - Prof. Prafulla Kerkar

All credits: Prof. Prafulla Kerkar

A Conference Talk by:Prof. Prafulla Kerkar,Presented at: 8th PVRI Annual World Congress, Guangzhou, China

Additional keywords: clinical trials,India,regulation

Latest PVD abstracts from PubMed

Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Not Associated With Reduced Myocardial Infarction in Smokers.

Authors: Oni OA, Sharma R, Chen G, Sharma M, Gupta K, Dawn B, Sharma R, Parashara D, Savin VJ, Cherian G, Ambrose JA, Barua RS Source: Mayo Clin Proc Innov Qual Outcomes

Pulmonary arterial compliance is a useful predictor of pulmonary vascular disease in congenital heart disease.

Authors: Muneuchi J, Ochiai Y, Masaki N, Okada S, Iida C, Sugitani Y, Ando Y, Watanabe M Source: Heart Vessels

Antiviral therapy effectively improves liver hemodynamics as evidenced by serum biomarker and contrast-enhanced ultrasound examinations in patients with hepatitis B cirrhosis.

Authors: Xu X, Zhang C, Shi C, Hu N, Sun B, Kong D, Xu J Source: PeerJ

Length of Stay Following Thoracic Endovascular Aortic Repair (TEVAR) Depends on Indication and Acuity.

Authors: Belkin N, Jackson BM, Foley PJ, Damrauer SM, Kalapatapu V, Golden MA, Fairman RM, Kelz RR, Wang GJ Source: Ann Vasc Surg

Scleral buckling in the management of rhegmatogenous retinal detachment: patient selection and perspectives.

Authors: Park SW, Lee JJ, Lee JE Source: Clin Ophthalmol

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI

Related Content

{{GlobalController.truncateTitle("Why Asia Offers Good Opportunities for Clinical Trials - Dr. Kevin Laliberte", 65)}}

{{GlobalController.truncateTitle("Lewis Rubin - Current Guidelines", 65)}}

{{GlobalController.truncateTitle("Majdy Idrees - Ensuring best quality of care in developing countries", 65)}}

{{GlobalController.truncateTitle("Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension ", 65)}}

{{GlobalController.truncateTitle(" Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension", 65)}}

Add to reading list

Share this content

Our research platform is the world.